264 related articles for article (PubMed ID: 31695352)
1. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F
Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
3. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
[TBL] [Abstract][Full Text] [Related]
4. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
[TBL] [Abstract][Full Text] [Related]
5. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
6. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
7. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
[TBL] [Abstract][Full Text] [Related]
8. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
9. Proteoglycan 4 is a diagnostic biomarker for COPD.
Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC
Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097
[TBL] [Abstract][Full Text] [Related]
10. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
12. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
[TBL] [Abstract][Full Text] [Related]
13. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
15. Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status.
Fireman Klein E; Adir Y; Krencel A; Peri R; Vasserman B; Fireman E; Kessel A
Int J Chron Obstruct Pulmon Dis; 2019; 14():557-564. PubMed ID: 30880945
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease.
Ban WH; Kang HH; Kim IK; Ha JH; Joo H; Lee JM; Lim JU; Lee SH; Rhee CK
Korean J Intern Med; 2018 Jul; 33(4):745-752. PubMed ID: 29529843
[TBL] [Abstract][Full Text] [Related]
17. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
18. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
20. Can we predict the prognosis of COPD with a routine blood test?
Xiong W; Xu M; Zhao Y; Wu X; Pudasaini B; Liu JM
Int J Chron Obstruct Pulmon Dis; 2017; 12():615-625. PubMed ID: 28243079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]